Fintel reports that on November 18, 2025, UBS maintained coverage of Chimera Investment (NYSE:CIM) with a Buy recommendation.

These Marvel villains were awesome and could be the next big thing, but they haven't made nearly enough appearances over the ...

This collection of episodes proves that the right plan and execution when developing an overarching storyline can elevate an ...

The indie-pop artist, who released his third album 'Chasing the Chimera' on Friday, Nov. 7, also reflected on opening for Niall Horan on tour ...

Mitty is a tragic consequence of human curiosity gone too far. As a victim of cruel experiments attempting to understand the Abyss’s curse, she loses her human form but retains her consciousness. She ...

There are many iconic anime duos, but Edward and Alphonse Elric are a elite class of their own. They fight, they bicker, they ...

A love of farming that began with a teenager’s two-acre cucumber field has grown into one of the country's most unique ...

After bursting onto Abu Dhabi’s investment scene, Lunate has transformed itself into a prolific dealmaker, striking ...

Johnson & Johnson stock rises on strong earnings, the Halda deal, FDA wins and an upcoming orthopedics spinoff as analysts weigh the outlook.

Kiara Takanashi and Ninomae Ina'nis will perform a concert together in March 2026, and all three Hololive English Myth ...

From the Turkey Trot to Dazzling Nights to the Winter Warmer Beer Festival, here's what to do in Pittsburgh during ...

(Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation, today announced that multiple abstracts on vepdegestrant (ARV-471) have been ...